z-logo
open-access-imgOpen Access
Chylous Ascites: Evaluation and Management
Author(s) -
Said A. AlBusafi,
Peter Ghali,
Marc Deschênes,
Philip Wong
Publication year - 2014
Publication title -
isrn hepatology
Language(s) - English
Resource type - Journals
ISSN - 2314-4041
DOI - 10.1155/2014/240473
Subject(s) - chylous ascites , medicine , ascites , malignancy , cirrhosis , paracentesis , lymphatic system , lymph , peritoneovenous shunt , ascitic fluid , gastroenterology , chyle , transjugular intrahepatic portosystemic shunt , abdominal cavity , peritoneal cavity , surgery , portal hypertension , pathology , complication
Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal malignancy, cirrhosis, and tuberculosis are the commonest causes of CA in adults, the latter being most prevalent in developing countries, whereas congenital abnormalities of the lymphatic system and trauma are commonest in children. The presence of a milky, creamy appearing ascitic fluid with triglyceride content above 200 mg/dL is diagnostic, and, in the majority of cases, unless there is a strong suspicion of malignancy, further investigations are not required in patients with cirrhosis. If an underlying cause is identified, targeted therapy is possible, but most cases will be treated conservatively, with dietary support including high-protein and low-fat diets supplemented with medium-chain triglycerides, therapeutic paracentesis, total parenteral nutrition, and somatostatins. Rarely, resistant cases have been treated by transjugular intrahepatic portosystemic shunt, surgical exploration, or peritoneovenous shunt.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom